Vienna, Austria

Manfred Hirnschall

This inventor holds 1 USPTO granted patent. Top assignee: Sanochemia Pharmazeutika Ag. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manfred Hirnschall. Retrieved from https://idiyas.com/inventor/manfred-hirnschall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manfred Hirnschall: Innovator in Pharmaceutical Chemistry

Introduction

Manfred Hirnschall is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new compounds. His work has led to advancements that may benefit various therapeutic applications.

Latest Patents

Hirnschall holds a patent for "Derivatives and analogs of galanthamine - New compounds of general formula I." This patent represents his innovative approach to enhancing the efficacy of galanthamine derivatives, which are important in treating cognitive disorders.

Career Highlights

Throughout his career, Manfred Hirnschall has been associated with Sanochemia Pharmazeutika AG, a company dedicated to pharmaceutical development. His expertise in chemistry and drug formulation has positioned him as a key figure in the industry.

Collaborations

Hirnschall has collaborated with esteemed colleagues such as Johannes Frohlich and Beate Kälz. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Manfred Hirnschall's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a significant inventor in the field. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…